Browsing byAuthorTate, MD
Showing results 1 to 3 of 3
| Issue Date | Title | Author(s) |
| 2018-03-02 | Defining the distinct, intrinsic properties of the novel type i interferon, IFNϵ | Stifter, SA; Matthews, AY; Mangan, NE; Fung, KY; Drew, A; Tate, MD; Soares Da Costa, TP; Hampsey, D; Mayall, J; Hansbro, PM; Minambres, AG; Eid, SG; Mak, J; Scoble, J; Lovrecz, G; DeWeerd, NA; Hertzog, PJ |
| 2019-10-01 | RIPLET, and not TRIM25, is required for endogenous RIG-I-dependent antiviral responses | Hayman, TJ; Hsu, AC; Kolesnik, TB; Dagley, LF; Willemsen, J; Tate, MD; Baker, PJ; Kershaw, NJ; Kedzierski, L; Webb, AI; Wark, PA; Kedzierska, K; Masters, SL; Belz, GT; Binder, M; Hansbro, PM; Nicola, NA; Nicholson, SE |
| 2017-02-14 | Suppressor of cytokine signaling (SOCS)5 ameliorates influenza infection via inhibition of EGFR signaling | Kedzierski, L; Tate, MD; Hsu, AC; Kolesnik, TB; Linossi, EM; Dagley, L; Dong, Z; Freeman, S; Infusini, G; Starkey, MR; Bird, NL; Chatfield, SM; Babon, JJ; Huntington, N; Belz, G; Webb, A; Wark, PA; Nicola, NA; Xu, J; Kedzierska, K; Hansbro, PM; Nicholson, SE |
